VolitionRx issues shares to satisfy debt obligations and completes private placement
#VolitionRx #VNRX #debt #equity #issuance #private placement #SEC #liquidity #NYSE American #regulatory exemptions #diagnostic testing #Japan #USA #Asia
📌 Key Takeaways
- VolitionRx issued shares to satisfy debt obligations totaling $1.72 million to Lind Global Asset Management XII LLC.
- A private placement on September 18, 2025, raised $300,000 through the issuance of shares and warrants.
- The company relied on exemptions from registration under the Securities Act of 1933 and Regulation D for both issuances.
- VolitionRx is facing liquidity pressure, with short-term obligations exceeding liquid assets (current ratio of 0.12).
- The company received a compliance notice from NYSE American regarding stockholders' equity requirements due to fiscal losses.
- Recent developments include progress on diagnostic test programs (e.g., reimbursement submission in France for lung cancer assay) and expansion of market reach through distributor appointments in Japan, US, and Asia.
📖 Full Retelling
VolitionRx Limited (NYSE:VNRX) reported unregistered equity issuances to satisfy debt obligations and a prior private placement, as detailed in a Securities and Exchange Commission filing. The company issued shares to Lind Global Asset Management XII LLC to cover $416,666, $583,334, and $416,666 payment obligations related to a $7.5 million promissory note. Separately, a private placement occurred on September 18, 2025, involving the issuance of shares and warrants for $300,000 to an existing securityholder under regulatory exemptions. These actions occur as VolitionRx faces liquidity challenges with short-term obligations exceeding liquid assets, and has recently received a compliance notice from NYSE American regarding stockholders' equity requirements.
🏷️ Themes
Debt Restructuring, Equity Issuance, Liquidity Issues, Regulatory Compliance, Market Expansion, Diagnostic Testing
Entity Intersection Graph
No entity connections available yet for this article.
Original Source
try{ var _=i o; . if(!_||_&&typeof _==="object"&&_.expiry Middle East tensions rise as Iran promises retaliation $100+ oil back in play if Hormuz disruption worsens: analysts Wait for a 10% drop in the S&P 500 before buying the dip, Barclays says U.S. dollar seen strengthening as U.S.-Israel strikes intensify (South Africa Philippines Nigeria) VolitionRx issues shares to satisfy debt obligations and completes private placement By Investing.com SEC Filings Published 03/01/2026, 09:36 AM VolitionRx issues shares to satisfy debt obligations and completes private placement 0 VNRX -9.36% VolitionRx Limited (NYSE:VNRX) reported a series of unregistered equity issuances related to debt repayment and a prior private placement, according to a press release statement filed with the Securities and Exchange Commission. The stock currently trades at $0.21 with a market cap of $29.29 million, down 69% over the past six months. On February 17, VolitionRx issued 1,956,178 shares of common stock to Lind Global Asset Management XII LLC to satisfy a $416,666 payment obligation under a senior secured convertible promissory note. The company previously issued 2,569,753 shares on January 29 and 1,893,936 shares on January 16 to Lind, satisfying payment obligations of $583,334 and $416,666, respectively. These issuances are part of a $7.5 million note originally issued under a securities purchase agreement dated May 15, 2025, and amended on January 7, 2026.An InvestingPro analysis reveals the company is quickly burning through cash, with short-term obligations exceeding liquid assets. The current ratio stands at just 0.12, indicating significant liquidity pressure. These are just 2 of 9 ProTips available, alongside comprehensive financial health metrics and Fair Value analysis showing the stock as undervalued . The shares were issued to an existing securityholder without paid commissions, public offering, or general solicitation. The company relied on exemptions from registration provided...
Read full article at source